Literature DB >> 28609209

Creation of a human T-ALL cell line online database.

Barbara Squiban1, Syed Talha Ahmed1, J Kimble Frazer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28609209      PMCID： PMC5526728          DOI： 10.1080/10428194.2017.1300896

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  8 in total

1.  Cell Biology. Fixing problems with cell lines.

Authors:  Jon R Lorsch; Francis S Collins; Jennifer Lippincott-Schwartz
Journal:  Science       Date:  2014-12-19       Impact factor: 47.728

Review 2.  Check your cultures! A list of cross-contaminated or misidentified cell lines.

Authors:  Amanda Capes-Davis; George Theodosopoulos; Isobel Atkin; Hans G Drexler; Arihiro Kohara; Roderick A F MacLeod; John R Masters; Yukio Nakamura; Yvonne A Reid; Roger R Reddel; R Ian Freshney
Journal:  Int J Cancer       Date:  2010-07-01       Impact factor: 7.396

3.  p53 mutations in colorectal cancer.

Authors:  N R Rodrigues; A Rowan; M E Smith; I B Kerr; W F Bodmer; J V Gannon; D P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  False leukemia-lymphoma cell lines: an update on over 500 cell lines.

Authors:  H G Drexler; W G Dirks; Y Matsuo; R A F MacLeod
Journal:  Leukemia       Date:  2003-02       Impact factor: 11.528

5.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.

Authors:  Elaine Coustan-Smith; Charles G Mullighan; Mihaela Onciu; Frederick G Behm; Susana C Raimondi; Deqing Pei; Cheng Cheng; Xiaoping Su; Jeffrey E Rubnitz; Giuseppe Basso; Andrea Biondi; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Lancet Oncol       Date:  2009-01-13       Impact factor: 41.316

6.  Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line.

Authors:  V T Chow; H H Quek; E P Tock
Journal:  Cancer Lett       Date:  1993-09-30       Impact factor: 8.679

7.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.

Authors:  Adolfo A Ferrando; Donna S Neuberg; Jane Staunton; Mignon L Loh; Christine Huard; Susana C Raimondi; Fred G Behm; Ching Hon Pui; James R Downing; D Gary Gilliland; Eric S Lander; Todd R Golub; A Thomas Look
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

Review 8.  Gene expression profiling in T-cell acute lymphoblastic leukemia.

Authors:  Adolfo A Ferrando; A Thomas Look
Journal:  Semin Hematol       Date:  2003-10       Impact factor: 3.851
  8 in total
  3 in total

1.  Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia.

Authors:  Mengping Xi; Shanshan Guo; Caicike Bayin; Sophie Rousseaux; Saadi Khochbin; Jian-Qing Mi; Jin Wang; Lijun Peng; Florent Chuffart; Ekaterina Bourova-Flin
Journal:  Front Med       Date:  2021-10-20       Impact factor: 9.927

2.  hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of PTEN and BIM Tumor Suppressor Genes and Modulate Survival of T-ALL Cells In Vitro.

Authors:  Monika Drobna; Bronisława Szarzyńska; Roman Jaksik; Łukasz Sędek; Anna Kuchmiy; Tom Taghon; Pieter Van Vlierberghe; Tomasz Szczepański; Michał Witt; Małgorzata Dawidowska
Journal:  Cells       Date:  2020-05-05       Impact factor: 6.600

3.  Adipocyte-mediated epigenomic instability in human T-ALL cells is cytotoxic and phenocopied by epigenetic-modifying drugs.

Authors:  Miyoung Lee; Delaney K Geitgey; Jamie A G Hamilton; Jeremy M Boss; Christopher D Scharer; Jennifer M Spangle; Karmella A Haynes; Curtis J Henry
Journal:  Front Cell Dev Biol       Date:  2022-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.